News
BEP is a combination chemotherapy treatment that healthcare professionals primarily use for treating testicular cancer. They may also use BEP to treat certain types of ovarian cancer and tumors ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In a report released today, Christine Cho CFA from Barclays initiated coverage with a Hold rating on Brookfield Renewable Partners (BEP – Research Report) and a price target of $27.00.
In a report released today, Robert Kad from Morgan Stanley maintained a Buy rating on Brookfield Renewable Partners (BEP – Research Report), with a price target of $32.00. The company’s shares ...
Education news: Long odds all that remain between Athlos Academy and closure Minneapolis-based WhiteBox Marketing helped with ...
Thursday marks 27 years since the U.S. Food and Drug Administration approved the sale of Viagra, the nation’s first oral medication for what’s now commonly known as erectile dysfunction.
Before the vessel was approved, one F.D.A. medical reviewer pointed out that 37 of the 54 patients were not assessed in a safety check four months after getting the implant, with many dead or lost ...
A former U.S. FDA employee said he and other agency reviewers were pressured to approve Humacyte's (NASDAQ:HUMA) Symvess, an artificial blood vessel, despite safety concerns. The implantable ...
The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results